TYMP and breast cancer: Thus, discovered that valproic acid increased the activity of capecitabine in breast cancer cells after suppressing histone deacetylase 3; although, this impact was eliminated in cells lacking thymidine phosphorylase (Terranova-Barberio et al., 2016).